Home – Company | About us | Who we are
A global quality and innovation led viral vector CDMO
Delivering end-to-end CDMO solutions at clinical and commercial scale.
OXB is one of the original pioneers in gene and cell therapy
We are proud to be recognized by Fortune as one of Europe’s Most Innovative Companies in 2025
OXB is a global, full-service, quality and innovation-led viral vector CDMO (Contract Development and Manufacturing Organisation), with deep expertise in the development, scale-up, and GMP-compliant manufacture of cell and gene therapy products.
With over 30 years of experience, we are a trusted partner to leading biopharma companies, offering a variety of CDMO solutions ranging from proprietary platforms, fully customised solutions and tech transfer, across the viral vector lifecycle.
Group at a glance
OXB was founded in 1995 as a spin-out from the University of Oxford, with a mission to harness the potential of gene and cell therapy to transform medicine. Over the past three decades, we have grown from a pioneering research venture into a leading global contract development and manufacturing organisation (CDMO) specialising in viral vectors.
Today, with cutting-edge facilities in the UK, Europe and US, deep expertise across multiple vector platforms, and a track record of successful global partnerships, OXB works at the forefront of advanced therapies to help bring life-changing treatments to patients worldwide.
0
Number of clients
0
Client programmes
0
Facilities
0
Number of employees
*As of April 2025
Mission, vision and values
Mission
To transform lives through cell and gene therapy.
Vision
Navigating complex regulatory landscapes to ensure compliance and facilitate timely product development.
Values:
Responsible
We are committed to excellence, and we act responsibly and do the right thing for our business, each other, our clients, communities, the environment, and ultimately, patients.
Responsive
We excel by being responsive to the needs of our clients, patients and industry through our innovation and delivery.
Resilient
We are strong together and rise to the challenge to build a resilient business, supporting each other and leveraging our collective strengths.
Respect
We build trust with each other and our clients by being open and honest, and by valuing each other’s strengths to create a sense of belonging.
Our people
Our success is driven by our people - world-class scientists, engineers, and leaders united by a commitment to advancing cell and gene therapies. Our experienced Board and Leadership Team guide OXB’s vision and strategy to deliver successful therapies for our diverse range of clients across the globe.
Our clients
Global infrastructure
OXB operates state-of-the-art GMP facilities across the UK, US, and France, forming a robust and resilient global manufacturing network. With multi-vector capabilities and alignment to global regulatory standards, our infrastructure empowers partners to scale with confidence and agility.